Venus Medtech (Hangzhou), Inc. Class H (2500) Financial Statements

Venus Medtech (Hangzhou), Inc. Class H's market cap is currently HK$1.12B. The company's EPS TTM is HK$-0.3463389192; its P/E ratio is -1.59; Venus Medtech (Hangzhou), Inc. Class H is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.